omeprazole has been researched along with Enteritis in 5 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Enteritis: Inflammation of any segment of the SMALL INTESTINE.
Excerpt | Relevance | Reference |
---|---|---|
" Therefore, we evaluated the biological effects of lansoprazole, a PPI used in the clinical area, in the setting of experimental rat non-steroidal anti-inflammatory drug-induced enteritis." | 7.73 | Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. ( Ichikawa, H; Kuroda, M; Naito, Y; Okanoue, T; Okuda, T; Takagi, T; Yoshida, N; Yoshikawa, T, 2006) |
" Therefore, we evaluated the biological effects of lansoprazole, a PPI used in the clinical area, in the setting of experimental rat non-steroidal anti-inflammatory drug-induced enteritis." | 3.73 | Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. ( Ichikawa, H; Kuroda, M; Naito, Y; Okanoue, T; Okuda, T; Takagi, T; Yoshida, N; Yoshikawa, T, 2006) |
"Cotreatment with omeprazole did not reduce indomethacin-induced intestinal bleeding." | 1.42 | Suppression of contractile activity in the small intestine by indomethacin and omeprazole. ( Bhattarai, D; Dial, EJ; Lichtenberger, LM; Phan, TM; Uray, K, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lichtenberger, LM | 1 |
Bhattarai, D | 1 |
Phan, TM | 1 |
Dial, EJ | 1 |
Uray, K | 1 |
Kuroda, M | 1 |
Yoshida, N | 1 |
Ichikawa, H | 1 |
Takagi, T | 1 |
Okuda, T | 1 |
Naito, Y | 1 |
Okanoue, T | 1 |
Yoshikawa, T | 1 |
Ottewell, PD | 1 |
Duckworth, CA | 1 |
Varro, A | 1 |
Dimaline, R | 1 |
Wang, TC | 1 |
Watson, AJ | 1 |
Dockray, GJ | 1 |
Pritchard, DM | 1 |
Stämpfli, H | 1 |
Oliver, OE | 1 |
Littman, A | 1 |
5 other studies available for omeprazole and Enteritis
Article | Year |
---|---|
Suppression of contractile activity in the small intestine by indomethacin and omeprazole.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Enteritis; Gastrointestinal Hemorrhage | 2015 |
Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemokine | 2006 |
Gastrin increases murine intestinal crypt regeneration following injury.
Topics: Animals; Benzodiazepinones; Cell Line; Cell Proliferation; Colitis; Dextran Sulfate; Enteritis; Enzy | 2006 |
Chronic diarrhea and weight loss in three horses.
Topics: Animals; Anti-Ulcer Agents; Desulfovibrionaceae Infections; Diarrhea; Endoscopy, Gastrointestinal; E | 2006 |
Potent acid reduction and risk of enteric infection.
Topics: Cholera; Enteritis; Gastric Acid; Humans; Omeprazole; Travel | 1990 |